Dogs of the ASX: The Best and Worst ASX 200 Performers of FY2026 — and the EOFY Tax-Loss Selling Trap

Q: What is the Dingoes of the ASX?

Dingoes of the ASX is the Australian nickname for the Dogs of the Dow adaptation. Investors rank a blue-chip universe - usually the S&P/ASX 50 - by dividend yield on the first trading day of the year, buy the 10 highest-yielding companies, hold them unchanged, and rebalance at year-end. The mechanics match the US original; the market's bank-and-miner concentration is what differs.

Christopher Hall
4 days ago
18 min read

Written by Christopher Hall, AdvDipFP | Authorised Representative, AFSL 526688 | July 2026

The best-performing ASX 200 stock of FY2026 was 4DMedical (ASX: 4DX), up roughly +1,749% on a total-return basis, followed by Minerals 260 (MI6, +535%) and Elevra Lithium (ELV, +327%) — a top 20 dominated by rare-earth, lithium, gold and mining-services names. The worst performers were led by WiseTech Global (WTC, −69%), Tuas (TUA, −61%), Xero (XRO, −60%), Cochlear (COH, −59%) and CSL (−50%) — high-multiple technology and healthcare compounders that de-rated hard while the S&P/ASX 200 index returned just +2.8% for the year. This article ranks the full top 20 and bottom 20 ASX 200 performers for the 2026 financial year, then explains the "Dogs of the Dow" (or "Dingoes of the ASX") contrarian strategy and the end-of-financial-year tax-loss selling overlay that makes the year's biggest losers a watchlist worth understanding — and a trap worth respecting.

What Were the Best-Performing ASX 200 Stocks in FY2026?

The FY2026 leaderboard was a resources story. Of the 20 best total-return performers in the S&P/ASX 200 over the financial year to 30 June 2026, the large majority were rare-earth, lithium, gold, copper and mining-services companies — the cyclical, commodity-leveraged end of the market rather than the blue-chip industrials and banks that anchor most income portfolios.

The standout was 4DMedical (ASX: 4DX), a respiratory imaging technology company that returned roughly +1,749% over the year, ahead of a cluster of critical-minerals names: Minerals 260 (MI6), Elevra Lithium (ELV), PLS Group / Pilbara (PLS) and defence-electronics group Electro Optic Systems (EOS). Diversified miner Mineral Resources (MIN) and mining-services contractors NRW Holdings (NWH) and SRG Global (SRG) rounded out the upper tier. Every one of the top 20 returned more than +70% — against a +2.8% return for the index itself.

Rank	Code	Company	Sector / theme	FY26 total return
1	4DX	4DMedical	Healthcare technology	+1,749%
2	MI6	Minerals 260	Gold / critical minerals	+535%
3	ELV	Elevra Lithium	Lithium	+327%
4	PLS	PLS Group (Pilbara)	Lithium	+270%
5	EOS	Electro Optic Systems	Defence technology	+256%
6	MIN	Mineral Resources	Diversified mining	+185%
7	NWH	NRW Holdings	Mining services	+155%
8	LTR	Liontown Resources	Lithium	+142%
9	SRG	SRG Global	Mining / engineering services	+139%
10	CDA	Codan	Electronics / communications	+123%
11	LYC	Lynas Rare Earths	Rare earths	+115%
12	KCN	Kingsgate Consolidated	Gold	+110%
13	ILU	Iluka Resources	Mineral sands / rare earths	+92%
14	ALK	Alkane Resources	Gold	+92%
15	MND	Monadelphous	Mining / energy services	+85%
16	SGM	Sims	Metal recycling	+81%
17	IGO	IGO	Lithium / nickel	+78%
18	PDI	Predictive Discovery	Gold	+77%
19	AAI	Alcoa	Aluminium	+73%
20	SFR	Sandfire Resources	Copper	+73%

The thematic signal matters more than any single name. When the year's leaders cluster this tightly in rare earths, lithium and gold, it tells investors the FY2026 advance was driven by a commodity and critical-minerals cycle, not a broad market melt-up. The same observation underpins how momentum traders read leadership: as Finer Market Points has documented, the way ASX sector strength clusters is often a more reliable signal than picking individual stocks. Readers tracking this dynamic can review how to identify leading sectors before the catalyst arrives and the sector-specific behaviour of mining-stock breakouts.

Performance data reflects ASX 200 constituents as at 30 June 2026; total return combines share-price change and dividends over the financial year. Past performance is no guarantee of future results, and all trading involves risk.

What Were the Worst-Performing ASX 200 Stocks in FY2026?

The bottom of the table was the mirror image of the top: expensive growth and quality, not cheap cyclicals. The 20 weakest total-return performers in the ASX 200 over FY2026 were led by high-multiple technology and healthcare compounders — the names that had spent years commanding premium valuations.

Software group WiseTech Global (ASX: WTC) was the weakest performer at −69%, ahead of telecommunications group Tuas (TUA, −61%), accounting-software group Xero (XRO, −60%), hearing-implant maker Cochlear (COH, −59%) and biotechnology giant CSL (−50%). Property portal REA Group (REA), jobs platform Seek (SEK), wealth-platform Netwealth (NWL) and radiology-software group Pro Medicus (PME) also featured — a roll-call of the market's most-loved structural-growth stories.

Rank	Code	Company	Sector / theme	FY26 total return
1	WTC	WiseTech Global	Software / logistics tech	−69%
2	TUA	Tuas	Telecommunications	−61%
3	XRO	Xero	Software / accounting	−60%
4	COH	Cochlear	Medical devices	−59%
5	CSL	CSL	Biotechnology	−50%
6	SEK	Seek	Online classifieds	−42%
7	JDO	Judo Capital	Banking (SME)	−41%
8	REA	REA Group	Online classifieds	−40%
9	ARB	ARB Corporation	Auto accessories	−39%
10	TWE	Treasury Wine Estates	Consumer staples	−37%
11	NWL	Netwealth	Investment platform	−37%
12	LLC	Lendlease	Real estate / construction	−35%
13	ASB	Austal	Defence shipbuilding	−35%
14	GDG	Generation Development	Financials	−33%
15	TLX	Telix Pharmaceuticals	Biotechnology	−31%
16	GQG	GQG Partners	Funds management	−31%
17	BPT	Beach Energy	Oil & gas	−30%
18	GNC	GrainCorp	Agribusiness	−30%
19	CAR	CAR Group	Online classifieds	−28%
20	PME	Pro Medicus	Healthcare software	−28%

This is the detail that reframes the whole "dogs" conversation. The classic Dogs of the Dow strategy hunts for beaten-down, high-yielding blue chips. But FY2026's ASX dogs are overwhelmingly low-yield growth and quality names — CSL, Cochlear, WiseTech, Xero, REA and Pro Medicus do not screen as high-dividend stocks at all. A list of the year's worst performers and a list of the highest-yielding "dogs" are not the same list in 2026, and conflating them is the first analytical error to avoid. Several of these names — CAR, SEK and PME among them — have already appeared in Finer Market Points' work on how leadership rotates between ASX sectors.

A low total return reflects share-price decline net of dividends over the period — it is a momentum observation, not a judgement on any company's underlying business. Past performance is no guarantee of future results, and all trading involves risk.

The FMP Momentum Profile — published daily and accessible to FMP YouTube Momentum Profile members — tracks the market conditions that form the context for thematic articles like this one. Members receive early access to the educational data discussed in each weekly session.

What Is the Dogs of the Dow Strategy — and How Does the ASX "Dingoes" Version Work?

The Dogs of the Dow is a contrarian, mean-reversion strategy that uses dividend yield as a cheapness signal. It was popularised by Michael B. O'Higgins in Beating the Dow (O'Higgins & Downes, 1992). The rule is deliberately mechanical: at the start of each calendar year, rank the 30 Dow Jones Industrial Average stocks by dividend yield, buy the 10 highest-yielding, hold for 12 months, then rebalance.

The logic rests on a single insight. A high dividend yield is often the arithmetic result of a falling share price, because yield rises as price falls. So the highest-yielding members of a blue-chip index are frequently its temporarily unloved names — companies the market has marked down but which still pay a substantial, often well-covered, dividend. The strategy bets that these "dogs" revert toward the mean while paying the investor to wait.

The most useful framing for a writer or investor is this: Dogs of the Dow is not really a dividend strategy — it is a mean-reversion strategy that uses dividend yield as a distress-and-cheapness proxy. The income is the carry; the rebound is the thesis.

The Australian version is often nicknamed the "Dingoes of the ASX." The method maps directly across:

1. Define the universe — typically the S&P/ASX 50 or ASX 100 blue chips (not the full ASX 200).

2. Rank by dividend yield on the first trading day of the year.

3. Buy the 10 highest-yielding companies in equal weight.

4. Hold unchanged for the year.

5. Rebalance at year-end, selling names that have re-rated out of the top 10 and adding new high-yielders.

The mechanics are identical to the US original. What changes — and it changes a lot — is the character of the Australian market the strategy is applied to.

Why Might the Dogs Strategy Behave Differently on the ASX?

Australia is structurally more dividend-focused than the United States, which both strengthens and complicates the Dogs approach. Franking credits, the dominance of banks and miners, persistent income demand from self-managed super funds (SMSFs), and a concentrated large-cap market all push Australian investors toward yield in a way US investors are not.

The scale of that tilt is measurable. S&P Dow Jones Indices reports that dividend-focused ETFs globally held more than A$990 billion in assets under management, and that in Australia the dividend factor represented more than A$6.5 billion — roughly 30% of the entire Australian factor-ETF market (S&P Dow Jones Indices, 2025). Income is not a niche on the ASX; it is close to a third of the factor market.

But the same concentration that makes yield investing popular makes the Dogs screen riskier here. On the ASX, the highest-yielding large caps cluster in banks, miners, insurers, infrastructure and mature industrials. A high yield in those sectors can signal genuine value — or it can flag a looming dividend cut, a cyclical earnings peak, commodity-price risk, or capital impairment. The yield that attracts the screen is sometimes the market correctly pricing a dividend that is about to fall.

This is the core hazard the strategy must manage: distinguishing a genuine high-yield opportunity from a dividend trap. Finer Market Points has examined exactly this question — when a fully franked dividend yield spikes after a selloff, is it an opportunity or a value trap? — and the answer turns on the sustainability of the payout, not the headline number.

How Does EOFY Tax-Loss Selling Change the Picture?

For an ASX article, the sharpest angle is not the calendar-year Dogs rule — it is what happens at 30 June. Australia's tax year ends on 30 June, not 31 December, and that single fact creates a behavioural distortion the US version never has to consider.

Tax-loss selling is the practice of selling loss-making positions before the end of the financial year to crystallise a capital loss, which can then be used to offset realised capital gains. The mechanic hinges on one rule. The Australian Taxation Office is explicit:

A capital loss can only be claimed once the shares or units are actually disposed of. An unrealised "paper" loss is not deductible (Australian Taxation Office, 2026).

The investor logic is well summarised by portfolio-tracking service Sharesight: tax-loss selling is most useful near EOFY because investors then have the clearest view of their realised gains and losses for the year. Capital losses offset capital gains, and the after-tax value of a loss depends on the holder: individuals and trusts currently receive the 50% CGT discount on gains held longer than 12 months, SMSFs receive one-third, and companies receive no CGT discount at all (Sharesight, 2026).

The behavioural consequence is the part that matters for the dogs. If enough investors sell the year's worst performers into late June to harvest losses, that selling pressure can push already-weak stocks even lower — temporarily, and for reasons that have nothing to do with the underlying business. When the financial year ticks over and the selling pressure lifts, fundamentally sound names can rebound. That is the July mean-reversion setup at the heart of the EOFY dogs thesis.

Is There Real Evidence of an ASX June/July Seasonal Effect?

The seasonal effect has a genuine academic anchor — and, helpfully, Australia is the textbook test case. The foundational study is Brown, Keim, Kleidon and Marsh (1983), Stock Return Seasonalities and the Tax-Loss Selling Hypothesis, published in the Journal of Financial Economics. The authors used Australia precisely because its July–June tax year predicts a July effect, where the US calendar tax year predicts the more famous January effect. If tax-loss selling drives the seasonality, Australian returns should be weak into June and strong in July.

Practitioner evidence points the same way. Bell Potter's long-running "Coppo on Tax-Loss Selling" research has found that tax-loss stocks tend to recover in July, with quantitative studies suggesting large caps bounce roughly +1% in July, while small caps that have fallen at least 5% recover about +2% (Bell Potter, 2021). The effect is consistently reported as stronger at the smaller, more retail-held end of the market.

How reliable is the trade? ShareCafe, reporting MST Marquee data, suggested the ASX tax-loss-selling trade has worked about 72% of the time since 2000 — though the same commentary cautioned that 2026 may differ because of proposed capital-gains-tax changes. A success rate near 72% is a meaningful edge, not a certainty, and the proposed CGT changes are exactly the kind of structural shift that can break a historical pattern.

The caution is as well-documented as the effect. Morningstar's local commentary notes that tax-loss harvesting may hasten falls in beaten-up shares, but stresses it is impossible to prove any particular stock's decline was caused by tax selling alone (Morningstar Australia, 2026). The Australian Financial Review has described the trade as a "timeless" ASX feature, with the biggest financial-year laggards typically seeing a wave of June selling, most pronounced among smaller, retail-owned names. And Firstlinks frames the opportunity side: tax-loss selling can leave quality companies oversold near EOFY when investors dump underperformers to offset gains made elsewhere (Firstlinks, 2024).

Remember that past performance is no guarantee of future results, and all trading involves risk.

How Do the FY2026 Dogs Line Up Against the Tax-Loss Selling Setup?

Combine the two ideas and a watchlist emerges — with a large warning attached. The Dogs of the Dow looks for unloved blue chips by ranking dividend yield. The ASX EOFY version adds a wrinkle: late-June tax-loss selling can temporarily depress the financial year's worst performers, creating a candidate list for a possible July rebound where the underlying business remains intact.

The FY2026 bottom 20 is where those candidates would be screened. But three cautions separate a sensible watchlist from a costly mistake:

• Cheap is not the same as value. Some of the year's dogs are simply oversold; others are signalling broken earnings, dividend risk, or genuine structural decline. The ranking alone cannot tell them apart.

• This year's dogs are not high-yielders. FY2026's worst performers are dominated by low-yield growth and quality names — CSL, Cochlear, WiseTech, Xero, REA, Pro Medicus. A pure highest-yield "Dingoes" screen would barely overlap with this list. The two strategies point at different stocks in 2026.

• Tax-loss selling is a timing distortion, not a buy signal. A June selloff driven by tax harvesting can make a stock cheaper without making it better. The distortion is a reason to look, never a reason to buy on its own.

The most defensible use of this data is as a research filter, not a trade. A stock that fell heavily over FY2026 and faces tax-loss selling pressure into 30 June and retains intact fundamentals is a candidate for further work. A stock that merely fell a long way is not. The same principle Finer Market Points applies to momentum leadership applies in reverse here: the relevant question is whether the selling reflects a temporary distortion or a genuine breakdown in the stock's relative strength.

How Can Investors Screen for ASX Dogs Without Buying a Value Trap?

A disciplined Dogs-style screen on the ASX runs in six steps, each designed to strip out the value traps the headline yield or headline loss would otherwise let through. This framework is educational — it is a way to organise research, not a recommendation to buy or sell any security.

Step 1 — Start with a blue-chip universe

Begin with the S&P/ASX 50 or ASX 100 rather than the full ASX 200. The Dogs logic depends on companies large and durable enough to mean-revert rather than disappear. Microcaps reward the screen with noise.

Step 2 — Rank by forward dividend yield, not trailing yield

Trailing yield reflects a dividend that has already been paid and may not be repeated. Forward (expected) yield is the relevant number, because the entire risk in a high-yield screen is whether the dividend survives the next 12 months.

Step 3 — Exclude obvious dividend traps

Screen out names where the payout looks unsustainable: a payout ratio stretched beyond earnings, active earnings downgrades, balance-sheet or debt stress, or a yield flattered by a commodity-cycle peak. This is the step that does the real work.

Step 4 — Overlay EOFY performance

Identify stocks that have fallen materially over the financial year, because those are the names most exposed to tax-loss selling pressure into 30 June. The overlay is what turns a generic yield screen into an EOFY-specific one.

Step 5 — Watch for post-EOFY relief

A July rebound is most plausible where the selling was technical (tax-driven) rather than fundamental. Where the business case remains intact, the lifting of June selling pressure can allow the price to recover.

Step 6 — Treat tax-loss selling as timing, not thesis

Use the EOFY distortion to refine when to look at a name already justified on fundamentals — never as the sole reason to own it. A cheap price created by tax selling is still attached to whatever caused the stock to be a candidate for tax selling in the first place.

The discipline is the strategy. Skipping Step 3 — the value-trap exclusion — is how a contrarian screen turns into a portfolio of falling knives. The yield or the loss gets you to the candidate list; the exclusions are what keep you out of the names that deserved to fall.

What Tax Traps Must Investors Avoid Near 30 June?

The single biggest compliance hazard is the wash sale. The ATO has a clear anti-avoidance stance: selling a stock at a loss purely to crystallise the deduction and then quickly repurchasing the same or a substantially similar position can be treated as a wash sale. Where it applies, the ATO may disallow the loss and apply penalties or interest. Both Morningstar and Livewire have warned readers on exactly this point in their EOFY commentary.

This is why the "sell on 30 June, buy back on 1 July" framing is dangerous shorthand. A round-trip designed mainly to harvest a tax loss while retaining the same economic exposure is the precise arrangement the wash-sale rules target. The safer framing for any investor is structural: tax-loss selling may create temporary price pressure in the market, but an individual acting on their own portfolio must avoid wash-sale arrangements and should seek personal tax advice.

Timing is also tighter than many investors assume. Livewire's 2026 EOFY commentary noted that tax-loss transactions cluster in the final weeks before 30 June, and that after 24 June 2026 there were only four trading days left to finalise them. The combination of a hard deadline and a crowded trade is part of what produces the late-June price pressure in the first place.

This article is general information only and is not taxation advice. Investors should seek advice from a qualified tax adviser or accountant about their own circumstances.

Conclusion

FY2026 was a year of inversion on the ASX. The best performers clustered in rare earths, lithium, gold and mining services, led by 4DMedical, Minerals 260 and Elevra Lithium; the worst were a roll-call of premium-priced growth and quality compounders — WiseTech, Tuas, Xero, Cochlear and CSL. That split is the single most important context for any "dogs" discussion this year, because the financial year's biggest losers are emphatically not this year's highest-yielding stocks.

The Dogs of the Dow, and its "Dingoes of the ASX" adaptation, remains a coherent mean-reversion idea: use yield as a cheapness signal, buy the unloved blue chips, and let reversion plus income do the work. The Australian EOFY overlay adds a genuine, academically grounded seasonal distortion — weak Junes and firmer Julys — that has reportedly worked around 72% of the time since 2000. But the trap is permanent: cheap is not value, a tax-driven selloff is a timing distortion rather than a buy signal, and a falling knife does not become an opportunity simply because it is also a tax loss. The supporting market data discussed here is the kind reviewed in real time in Finer Market Points' weekly sessions, accessible to FMP YouTube Momentum Profile members.

This article draws on publicly available research data compiled for the Finer Market Points editorial program. The FMP Momentum Profile and Gary Glover's weekly session recordings — where ASX momentum stocks and the market conditions covered in thematic articles like this one are reviewed in real time — are accessible to FMP YouTube Momentum Profile members. Members receive early access to the educational data that forms the basis of articles like this one. For information on FMP YouTube Momentum Profile membership, visit the FMP YouTube Momentum Profile membership page.

Remember that past performance is no guarantee of future results, and all trading involves risk.

Frequently Asked Questions

What were the best-performing ASX shares in FY2026?

The best-performing ASX 200 stock of FY2026 by total return was 4DMedical (ASX: 4DX), up roughly +1,749%, followed by Minerals 260 (MI6, +535%), Elevra Lithium (ELV, +327%), PLS Group (PLS, +270%) and Electro Optic Systems (EOS, +256%). The top 20 was dominated by rare-earth, lithium, gold and mining-services companies, reflecting a commodity and critical-minerals cycle — every top-20 name returned more than +70% against a +2.8% return for the index.

What were the worst-performing ASX 200 shares in FY2026?

The weakest ASX 200 performers in FY2026 were led by WiseTech Global (WTC, −69%), Tuas (TUA, −61%), Xero (XRO, −60%), Cochlear (COH, −59%) and CSL (−50%). The bottom of the table was dominated by high-multiple technology and healthcare growth stocks that de-rated over the year, alongside names such as REA Group, Seek, Netwealth and Pro Medicus.

What is the Dogs of the Dow strategy?

The Dogs of the Dow is a contrarian investing strategy popularised by Michael O'Higgins in Beating the Dow (1992). Investors rank the 30 Dow stocks by dividend yield at the start of the year, buy the 10 highest-yielding, hold for 12 months, then rebalance. It is best understood as a mean-reversion strategy that uses high dividend yield as a signal of temporary cheapness.

What is the Dingoes of the ASX?

"Dingoes of the ASX" is the Australian nickname for the Dogs of the Dow adaptation. Investors rank a blue-chip universe — usually the S&P/ASX 50 — by dividend yield on the first trading day of the year, buy the 10 highest-yielding companies, hold them unchanged, and rebalance at year-end. The mechanics match the US original; the market's bank-and-miner concentration is what differs.

Does the Dogs of the Dow strategy work in Australia?

The strategy can work in Australia, where franking credits and SMSF income demand make high-yield investing widespread — S&P Dow Jones Indices put the Australian dividend factor at more than A$6.5 billion, roughly 30% of the local factor-ETF market. However, the high-yield names cluster in banks, miners and insurers, where a large yield can signal a looming dividend cut rather than value. The value-trap risk is higher than in the more diversified US index.

What is tax-loss selling on the ASX?

Tax-loss selling is the practice of selling loss-making shares before 30 June to crystallise a capital loss, which can then offset realised capital gains and reduce capital gains tax. The Australian Taxation Office only allows the loss once the shares are actually sold — an unrealised paper loss is not deductible. It is a tax-management technique, not an investment strategy.

When is the best time for tax-loss selling in Australia?

Tax-loss selling is most relevant in the weeks before 30 June, because investors then have the clearest view of their realised gains and losses for the financial year. Livewire noted that after 24 June 2026 only four trading days remained to finalise transactions. The clustering of this selling into late June is part of what creates the seasonal price pressure on weak stocks.

Do ASX stocks bounce back in July?

Historically, many tax-loss-affected ASX stocks have recovered in July once end-of-financial-year selling pressure lifts. Bell Potter's Coppo research has suggested large caps bounce roughly +1% in July, and small caps that fell at least 5% recover about +2%. The effect is reported to have worked around 72% of the time since 2000, though proposed CGT changes mean 2026 may differ.

Is tax-loss selling a buy signal?

No. Tax-loss selling is a timing distortion, not a buy signal. A June selloff driven by tax harvesting can make a stock cheaper without improving its underlying business. The distortion is a reason to research a name that is already justified on its fundamentals — never a standalone reason to buy a stock that fell heavily.

What is a dividend trap?

A dividend trap is a stock whose high dividend yield reflects a falling share price and an unsustainable payout, rather than genuine value. The yield looks attractive, but the dividend is at risk of being cut — at which point both the income and the share price can fall further. Screening forward dividend yield and payout sustainability, not trailing yield, is how investors try to avoid them.

What is a wash sale, and is it allowed in Australia?

A wash sale is selling an asset to crystallise a tax loss and then quickly repurchasing the same or a substantially similar asset to retain the economic exposure. The ATO treats wash sales as tax avoidance and can disallow the loss and apply penalties or interest. Selling on 30 June and buying back on 1 July to harvest a loss is exactly the arrangement the rules target, and investors should seek tax advice.

Why did stocks like CSL, Cochlear and WiseTech fall in FY2026?

CSL, Cochlear, WiseTech and similar names ranked among the worst ASX 200 total-return performers in FY2026 as high-multiple growth and quality stocks de-rated over the year. A low total return reflects share-price decline net of dividends — it is a momentum observation about price, not a judgement on any company's underlying business or prospects.

Sources

#	Source	Type
1	Christopher Hall, Finer Market Points. FY2026 ASX 200 performance dataset, as at 30 June 2026.	FMP proprietary data
2	O'Higgins, M.B. & Downes, J. Beating the Dow (HarperBusiness, 1992).	Published research
3	Brown, P., Keim, D.B., Kleidon, A.W. & Marsh, T.A. "Stock Return Seasonalities and the Tax-Loss Selling Hypothesis", Journal of Financial Economics (1983).	Published research
4	Australian Taxation Office. "When you can claim losses on shares and units" (ATO, 2026).	Government / regulatory
5	S&P Dow Jones Indices. "Analyzing High Dividend Yield Strategies in Australia" (S&P Global, 2025).	Published research
6	Bell Potter. "Coppo on Tax-Loss Selling" (Bell Potter, 2021).	Industry research
7	Sharesight. "Tax loss selling for Australian investors" (Sharesight, 29 April 2026).	Industry research
8	MST Marquee data, reported by ShareCafe (2026).	Industry research
9	Morningstar Australia. "Have these tax loss selling candidates fallen too far?" (2026); "Avoid this expensive tax-time mistake" (2023).	Industry research
10	Firstlinks. "Tax-loss selling creates opportunities in these 3 ASX stocks" (26 June 2024).	Industry research
11	Livewire Markets. EOFY tax-loss-selling commentary (2026).	Industry research
12	Australian Financial Review. ASX tax-loss-selling commentary (2026).	Industry research
13	Market Index. "Dogs of the Dow Down Under"; "Basics of Dividend Yield Investing Australia" (2022).	Industry research
14	CMC Invest. "Dogs of the Dow" (CMC Markets Australia, 2024).	Industry research

Related Finer Market Points Educational Resources

• Fully Franked Dividend Yield on the ASX: Opportunity or Value Trap? — Christopher Hall

• How ASX Momentum Traders Identify Sector Rotation Opportunities Before the Catalyst Arrives — Christopher Hall

• Relative Strength as a Leading Indicator for ASX Momentum Traders — Christopher Hall

• VCP Patterns in Mining Stocks: Sector-Specific Considerations — Christopher Hall

• From Energy to Growth: Identifying the Next ASX Market Leaders — Christopher Hall

About the Author

Christopher Hall, AdvDipFP, is an Authorised Representative (AFSL 526688) and the writer behind Finer Market Points, where he publishes educational analysis of ASX momentum trading and market structure for Australian investors. Read more at his author profile.

This content is for educational purposes only and does not constitute financial advice. Past performance is no guarantee of future results.

The information, opinions and other materials appearing on this website are of a general nature only and shall not be construed as advice. Finer Market Points Pty Ltd, CAR 1304002, AFSL 526688, ABN 87 645 284 680. This general information is educational only and not financial advice, recommendation, forecast or solicitation. This is not taxation advice. Rose Bay Equities accepts no responsibility for the accuracy or completeness of the information, opinions or other materials provided on or accessible through this website. This website has not been prepared with reference to your individual financial or personal circumstances. You should not rely on any advice on this website without first seeking appropriate professional, financial and legal advice. Further, where Rose Bay Equities makes third party material available or accessible through this website you acknowledge that Rose Bay Equities is a distributor and not a publisher of that content and that its editorial control is limited to the selection of those materials to make available. We accept no liability for any loss or damages arising from use.